Sourced from the Federal Register of Legislation (legislation.gov.au), CC BY 4.0.
1 National Health (Weighted average disclosed price - interim supplementary disclosure cycle) Determination 2012 (No. PB 58 of 2012)
PB 58 of 2012
National Health (Weighted average disclosed price – interim supplementary disclosure cycle) Determination 2012
as amended
made under subsection 99ADB(4) and paragraph 99ADH(1)(aa) of the
National Health Act 1953
This compilation was prepared on 5 November 2012
taking into account amendments up to PB 98 of 2012
Prepared by the Office of Parliamentary Counsel, Canberra
Contents
1 Name of Determination [see Note 1]
2 Commencement [see Note 1]
3 Definitions
4 Weighted average disclosed price for brands of pharmaceutical items – unadjusted price reduction is at least 10%
5 Weighted average disclosed price for brands of pharmaceutical items – unadjusted price reduction is less than 10%
6 Adjusted approved ex‑manufacturer price for brands of pharmaceutical items – unadjusted price reduction is at least 10%
7 Adjusted approved price to pharmacists for brands of pharmaceutical items – unadjusted price reduction is at least 10%
8 Reduction Day
Schedule 1 Brands of pharmaceutical items – unadjusted price reduction is at least 10%
Schedule 2 Brands of pharmaceutical items – unadjusted price reduction is less than 10%
Notes
1 Name of Determination [see Note 1]
(1) This Determination is the National Health (Weighted average disclosed price – interim supplementary disclosure cycle) Determination 2012.
(2) This Determination may also be cited as PB 58 of 2012.
2 Commencement [see Note 1]
This Determination commences on the day after it is registered.
3 Definitions
In this Determination:
Act means the National Health Act 1953.
adjusted approved ex‑manufacturer price has the same meaning as in subsection 99ADB(1) of the Act.
adjusted approved price to pharmacists has the same meaning as in subsection 99ADB(1) of the Act.
interim supplementary disclosure cycle has the same meaning as paragraph 37EB (2) (b), of the National Health (Pharmaceutical Benefits) Regulations 1960.